Jun 20, 2019 - Does Merck (MRK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Jun 20, 2019 - Wall Street closed higher on Wednesday after the Fed kept the federal fund target rate unchanged.
Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
Jun 21, 2019 - The index enjoyed another week of strong gains after the Federal Reserve indicated that a rate cut would likely occur next month.
Sep 05, 2019 - It’s rejected a pair of drugs in the last six months.
Sep 05, 2019 - Endo (ENDP) receives an FDA approval for the generic equivalent of Swedish Orphan Biovitrum's Orfadin.
Sep 05, 2019 - AstraZeneca's (AZN) Tagrisso gets a marketing approval in China for the first-line treatment of advanced or metastatic non-small cell lung cancer in patients with tumors having EGFR mutations.
Sep 10, 2019 - The Dow is expected to maintain its current momentum for the rest of this month and further due to two immediate catalysts.
Sep 11, 2019 - We discuss four pharma giants, which possess the industry's strongest oncology pipeline portfolios.
Sep 13, 2019 - Roche's (RHHBY) new fixed-dose combination of Perjeta and Herceptin meets the primary endpoint in the phase III study for treating patients with HER2-positive early breast cancer.